Annual Total Liabilities
$82.23 M
+$7.02 M+9.34%
31 December 2023
Summary:
Catalyst Pharmaceuticals annual total liabilities is currently $82.23 million, with the most recent change of +$7.02 million (+9.34%) on 31 December 2023. During the last 3 years, it has risen by +$59.48 million (+261.37%). CPRX annual total liabilities is now at all-time high.CPRX Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Liabilities
$111.07 M
+$13.36 M+13.68%
30 September 2024
Summary:
Catalyst Pharmaceuticals quarterly total liabilities is currently $111.07 million, with the most recent change of +$13.36 million (+13.68%) on 30 September 2024. Over the past year, it has increased by +$46.41 million (+71.77%). CPRX quarterly total liabilities is now at all-time high.CPRX Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CPRX Total Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +9.3% | +71.8% |
| 3 y3 years | +261.4% | +351.7% |
| 5 y5 years | +750.7% | +493.7% |
CPRX Total Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +261.4% | at high | +351.7% |
| 5 y | 5 years | at high | +750.7% | at high | +510.1% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% |
Catalyst Pharmaceuticals Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $111.07 M(+13.7%) |
| June 2024 | - | $97.70 M(+14.6%) |
| Mar 2024 | - | $85.26 M(+3.7%) |
| Dec 2023 | $82.23 M(+9.3%) | $82.23 M(+27.2%) |
| Sept 2023 | - | $64.66 M(-5.7%) |
| June 2023 | - | $68.60 M(-6.7%) |
| Mar 2023 | - | $73.57 M(-2.2%) |
| Dec 2022 | $75.21 M(+142.9%) | $75.21 M(+19.2%) |
| Sept 2022 | - | $63.07 M(+140.6%) |
| June 2022 | - | $26.22 M(-2.0%) |
| Mar 2022 | - | $26.75 M(-13.6%) |
| Dec 2021 | $30.96 M(+36.0%) | $30.96 M(+25.9%) |
| Sept 2021 | - | $24.59 M(+21.8%) |
| June 2021 | - | $20.19 M(+8.7%) |
| Mar 2021 | - | $18.57 M(-18.4%) |
| Dec 2020 | $22.76 M(-8.0%) | $22.76 M(+24.8%) |
| Sept 2020 | - | $18.23 M(-9.8%) |
| June 2020 | - | $20.21 M(+11.0%) |
| Mar 2020 | - | $18.20 M(-26.4%) |
| Dec 2019 | $24.75 M(+156.0%) | $24.75 M(+32.3%) |
| Sept 2019 | - | $18.71 M(+25.1%) |
| June 2019 | - | $14.95 M(+51.0%) |
| Mar 2019 | - | $9.90 M(+2.4%) |
| Dec 2018 | $9.67 M(+118.5%) | $9.67 M(+166.1%) |
| Sept 2018 | - | $3.63 M(+12.6%) |
| June 2018 | - | $3.23 M(+11.9%) |
| Mar 2018 | - | $2.88 M(-34.9%) |
| Dec 2017 | $4.42 M(+84.5%) | $4.42 M(+52.4%) |
| Sept 2017 | - | $2.90 M(+44.3%) |
| June 2017 | - | $2.01 M(-22.7%) |
| Mar 2017 | - | $2.60 M(+8.5%) |
| Dec 2016 | $2.40 M(-48.2%) | $2.40 M(-0.5%) |
| Sept 2016 | - | $2.41 M(-7.9%) |
| June 2016 | - | $2.62 M(-16.4%) |
| Mar 2016 | - | $3.13 M(-32.3%) |
| Dec 2015 | $4.63 M | $4.63 M(+18.2%) |
| Sept 2015 | - | $3.91 M(-29.4%) |
| June 2015 | - | $5.54 M(-41.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2015 | - | $9.43 M(+8.8%) |
| Dec 2014 | $8.67 M(+117.8%) | $8.67 M(-6.0%) |
| Sept 2014 | - | $9.22 M(+94.5%) |
| June 2014 | - | $4.74 M(+3.3%) |
| Mar 2014 | - | $4.59 M(+15.4%) |
| Dec 2013 | $3.98 M(+83.6%) | $3.98 M(-39.5%) |
| Sept 2013 | - | $6.58 M(+143.5%) |
| June 2013 | - | $2.70 M(+74.4%) |
| Mar 2013 | - | $1.55 M(-28.5%) |
| Dec 2012 | $2.17 M(-12.9%) | $2.17 M(-20.0%) |
| Sept 2012 | - | $2.71 M(+109.6%) |
| June 2012 | - | $1.29 M(-43.1%) |
| Mar 2012 | - | $2.27 M(-8.7%) |
| Dec 2011 | $2.49 M(+693.3%) | $2.49 M(+488.7%) |
| Sept 2011 | - | $422.70 K(-35.6%) |
| June 2011 | - | $656.10 K(-24.9%) |
| Mar 2011 | - | $873.10 K(+178.3%) |
| Dec 2010 | $313.70 K(-10.0%) | $313.70 K(-24.4%) |
| Sept 2010 | - | $414.80 K(-16.8%) |
| June 2010 | - | $498.60 K(+30.7%) |
| Mar 2010 | - | $381.40 K(+9.4%) |
| Dec 2009 | $348.50 K(-76.3%) | $348.50 K(+10.5%) |
| Sept 2009 | - | $315.30 K(-37.9%) |
| June 2009 | - | $507.40 K(-67.8%) |
| Mar 2009 | - | $1.58 M(+7.0%) |
| Dec 2008 | $1.47 M(+312.3%) | $1.47 M(+16.3%) |
| Sept 2008 | - | $1.27 M(+60.5%) |
| June 2008 | - | $788.90 K(+61.3%) |
| Mar 2008 | - | $489.10 K(+36.9%) |
| Dec 2007 | $357.20 K(-53.8%) | $357.20 K(-11.8%) |
| Sept 2007 | - | $405.10 K(-3.2%) |
| June 2007 | - | $418.50 K(-20.2%) |
| Mar 2007 | - | $524.30 K(-32.2%) |
| Dec 2006 | $772.80 K(+125.3%) | $772.80 K(+12.6%) |
| Sept 2006 | - | $686.50 K(+58.0%) |
| June 2006 | - | $434.40 K(+26.6%) |
| Dec 2005 | $343.00 K(+405.9%) | $343.00 K(+405.9%) |
| Dec 2004 | $67.80 K(+1.6%) | $67.80 K |
| Dec 2002 | $66.70 K | - |
FAQ
- What is Catalyst Pharmaceuticals annual total liabilities?
- What is the all time high annual total liabilities for Catalyst Pharmaceuticals?
- What is Catalyst Pharmaceuticals annual total liabilities year-on-year change?
- What is Catalyst Pharmaceuticals quarterly total liabilities?
- What is the all time high quarterly total liabilities for Catalyst Pharmaceuticals?
- What is Catalyst Pharmaceuticals quarterly total liabilities year-on-year change?
What is Catalyst Pharmaceuticals annual total liabilities?
The current annual total liabilities of CPRX is $82.23 M
What is the all time high annual total liabilities for Catalyst Pharmaceuticals?
Catalyst Pharmaceuticals all-time high annual total liabilities is $82.23 M
What is Catalyst Pharmaceuticals annual total liabilities year-on-year change?
Over the past year, CPRX annual total liabilities has changed by +$7.02 M (+9.34%)
What is Catalyst Pharmaceuticals quarterly total liabilities?
The current quarterly total liabilities of CPRX is $111.07 M
What is the all time high quarterly total liabilities for Catalyst Pharmaceuticals?
Catalyst Pharmaceuticals all-time high quarterly total liabilities is $111.07 M
What is Catalyst Pharmaceuticals quarterly total liabilities year-on-year change?
Over the past year, CPRX quarterly total liabilities has changed by +$46.41 M (+71.77%)